New Arsenal signing Eberechi Eze endured a difficult game for England on Saturday against Andorra, prompting criticism from Thomas Tuchel. Eze started as a number ten for the Three Lions, deployed on ...

Arsenal are set to be without William Saliba for up to a month after he picked up an injury but Mikel Arteta will not be sweating over his absence for two major reasons. Saliba has been brilliant for ...

PHILADELPHIA -- The only thing Jalen Carter did right on Thursday night? He didn't run and hide from dealing with the swarm of media he would inevitably face. Carter stood at the corner of his locker, ...

When you load into Roblox 99 Nights in the Forest, the first thing you’ll do is chop up trees to collect Logs. To make the process faster, play with the Lumberjack Class to gain additional Logs from ...

Alessia Russo has signed a new long-term contract with Arsenal. Russo, 26, has been an important figure for Arsenal since joining the club from Manchester United on a free transfer in July 2023. Her ...

Edwin Castro holds the record of largest lottery jackpot win with the November 2022 Powerball prize of $2.04 billion. Edwin Castro was the sole winner of the $2.04 billion Powerball. As they say in ...

The publisher of "Roblox" has promised to set up age verification mechanisms, after allegations the video game massively popular with children and teens worldwide has fallen short on safety. Roblox ...

A new study advises limited smartphone use to 5 minutes, as sitting on an “open toilet bowl” provides no support to the pelvic floor, leading to hemorrhoids Getty Scrolling on your phone while you sit ...

A new survey of businesses in Connecticut found that not surprisingly workforce shortages, the state’s high cost of living and the rising cost of doing business were among the largest challenges to ...

Sara Giordano does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, ...